FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3093417334> ?p ?o ?g. }

• W3093417334 endingPage "1442" @default.
• W3093417334 startingPage "1432" @default.
• W3093417334 abstract "Malignant melanoma is the deadliest skin cancer, due to its propensity to metastasize. MAPKs and NF‐κB pathways are constitutively activated in melanoma and promote cell proliferation, cell invasion, metastasis formation, and resistance to therapeutic regimens. Thus, they represent potential targets for melanoma prevention and treatment. Phytochemicals are gaining considerable attention for the management of melanoma because of their several cellular and molecular targets. A screening of a small library of sesquiterpenes lactones selected cynaropicrin, isolated from the aerial parts of Centaurea drabifolia subsp. detonsa , for its potential anticancer effect against melanoma cells. Treatment of human melanoma cells A375 with cynaropicrin resulted in inhibition of cell proliferation and induction of caspase‐3‐dependent apoptosis. Furthermore, cynaropicrin reduced several cellular malignant features such migration, invasion, and colonies formation through the inhibition of ERK1/2 and NF‐κB activity. Cynaropicrin was able to reduce intracellular reactive oxygen species generation, which are involved in all the stages of carcinogenesis. Indeed, cynaropicrin increased the expression of several antioxidant genes, such as glutamate–cysteine ligase and heme oxygenase‐1, by promoting the activation of the transcription factor Nrf‐2. In conclusion, our results individuate cynaropicrin as a potential adjuvant chemotherapeutic agent for melanoma by targeting several protumorigenic signaling pathways." @default.
• W3093417334 created "2020-10-22" @default.
• W3093417334 creator A5012386440 @default.
• W3093417334 creator A5032477247 @default.
• W3093417334 creator A5039104297 @default.
• W3093417334 creator A5048120503 @default.
• W3093417334 creator A5057541140 @default.
• W3093417334 creator A5057723638 @default.
• W3093417334 creator A5080001817 @default.
• W3093417334 date "2020-10-15" @default.
• W3093417334 modified "2023-10-18" @default.
• W3093417334 title "Inhibitory effects of cynaropicrin on human melanoma progression by targeting <scp>MAPK</scp> , <scp>NF‐κB,</scp> and Nrf‐2 signaling pathways in vitro" @default.
• W3093417334 cites W1483913375 @default.
• W3093417334 cites W1514882132 @default.
• W3093417334 cites W1580870868 @default.
• W3093417334 cites W1583657428 @default.
• W3093417334 cites W1964377459 @default.
• W3093417334 cites W1971488737 @default.
• W3093417334 cites W1980509967 @default.
• W3093417334 cites W2002015567 @default.
• W3093417334 cites W2021309474 @default.
• W3093417334 cites W2023753220 @default.
• W3093417334 cites W2073986458 @default.
• W3093417334 cites W2083071223 @default.
• W3093417334 cites W2097790191 @default.
• W3093417334 cites W2098131661 @default.
• W3093417334 cites W2124662474 @default.
• W3093417334 cites W2126505493 @default.
• W3093417334 cites W2132834292 @default.
• W3093417334 cites W2145990138 @default.
• W3093417334 cites W2343596022 @default.
• W3093417334 cites W2396494944 @default.
• W3093417334 cites W2551961464 @default.
• W3093417334 cites W2560283260 @default.
• W3093417334 cites W2590934724 @default.
• W3093417334 cites W2620803392 @default.
• W3093417334 cites W2621317769 @default.
• W3093417334 cites W2763050882 @default.
• W3093417334 cites W2766580429 @default.
• W3093417334 cites W2770631718 @default.
• W3093417334 cites W2802257937 @default.
• W3093417334 cites W2901353317 @default.
• W3093417334 cites W2943089406 @default.
• W3093417334 cites W2947493540 @default.
• W3093417334 cites W976610836 @default.
• W3093417334 doi "https://doi.org/10.1002/ptr.6906" @default.
• W3093417334 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33058354" @default.
• W3093417334 hasPublicationYear "2020" @default.
• W3093417334 type Work @default.
• W3093417334 sameAs 3093417334 @default.
• W3093417334 citedByCount "22" @default.
• W3093417334 countsByYear W30934173342021 @default.
• W3093417334 countsByYear W30934173342022 @default.
• W3093417334 countsByYear W30934173342023 @default.
• W3093417334 crossrefType "journal-article" @default.
• W3093417334 hasAuthorship W3093417334A5012386440 @default.
• W3093417334 hasAuthorship W3093417334A5032477247 @default.
• W3093417334 hasAuthorship W3093417334A5039104297 @default.
• W3093417334 hasAuthorship W3093417334A5048120503 @default.
• W3093417334 hasAuthorship W3093417334A5057541140 @default.
• W3093417334 hasAuthorship W3093417334A5057723638 @default.
• W3093417334 hasAuthorship W3093417334A5080001817 @default.
• W3093417334 hasConcept C104317684 @default.
• W3093417334 hasConcept C121608353 @default.
• W3093417334 hasConcept C181199279 @default.
• W3093417334 hasConcept C190283241 @default.
• W3093417334 hasConcept C203014093 @default.
• W3093417334 hasConcept C2776217839 @default.
• W3093417334 hasConcept C2777658100 @default.
• W3093417334 hasConcept C2777730290 @default.
• W3093417334 hasConcept C2779219270 @default.
• W3093417334 hasConcept C502942594 @default.
• W3093417334 hasConcept C54355233 @default.
• W3093417334 hasConcept C55493867 @default.
• W3093417334 hasConcept C555283112 @default.
• W3093417334 hasConcept C57074206 @default.
• W3093417334 hasConcept C62112901 @default.
• W3093417334 hasConcept C62478195 @default.
• W3093417334 hasConcept C86339819 @default.
• W3093417334 hasConcept C86803240 @default.
• W3093417334 hasConcept C95444343 @default.
• W3093417334 hasConceptScore W3093417334C104317684 @default.
• W3093417334 hasConceptScore W3093417334C121608353 @default.
• W3093417334 hasConceptScore W3093417334C181199279 @default.
• W3093417334 hasConceptScore W3093417334C190283241 @default.
• W3093417334 hasConceptScore W3093417334C203014093 @default.
• W3093417334 hasConceptScore W3093417334C2776217839 @default.
• W3093417334 hasConceptScore W3093417334C2777658100 @default.
• W3093417334 hasConceptScore W3093417334C2777730290 @default.
• W3093417334 hasConceptScore W3093417334C2779219270 @default.
• W3093417334 hasConceptScore W3093417334C502942594 @default.
• W3093417334 hasConceptScore W3093417334C54355233 @default.
• W3093417334 hasConceptScore W3093417334C55493867 @default.
• W3093417334 hasConceptScore W3093417334C555283112 @default.
• W3093417334 hasConceptScore W3093417334C57074206 @default.
• W3093417334 hasConceptScore W3093417334C62112901 @default.
• W3093417334 hasConceptScore W3093417334C62478195 @default.
• W3093417334 hasConceptScore W3093417334C86339819 @default.

• next